SERRETTI, ALESSANDRO
SERRETTI, ALESSANDRO
DIPARTIMENTO DI SCIENZE BIOMEDICHE E NEUROMOTORIE
Docenti di ruolo di IIa fascia
Alessandro Serretti; A. SERRETTI; Serretti A.; SERRETTI
22q11.2 rearrangements: clinical and research implications of population-based risk of neuropsychiatric and developmental disorders
2018-01-01 Fabbri, Chiara; Serretti, Alessandro
3111T/C clock gene polymorphism is not associated with sleep disturbances in untreated depressed patients
2010-01-01 Serretti A; Gaspar-Barba E; Calati R; Cruz-Fuentes CS; Gomez-Sanchez A; Perez-Molina A; De Ronchi D
5-HT(1A) polymorphism and self-transcendence in mood disorders
2005-01-01 Lorenzi C.; Serretti A.; Mandelli L.; Tubazio V.; Ploia C.; Smeraldi E.;
5-HT(2A) SNPs and the Temperament and Character Inventory
2007-01-01 Serretti A.; Calati R.; Giegling I.; Hartmann A.M.; Moller H.J.; Colombo C.; Rujescu D.
[5-HT1A gene polymorphisms contributed to antidepressant response in major depression].
2009-01-01 Kato M; Fukuda T; Wakeno M; Okugawa G; Takekita Y; Serretti A; Azuma J; Kinoshita T.
5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies
2008-01-01 Drago A.; De Ronchi D.; Serretti A.
5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients
2009-01-01 Kato M.; Zanardi R.; Rossini D.; De Ronchi D.; Okugawa G.; Kinoshita T.; Colombo C.; Serretti A.
5-HTTLPR and gender differences in affective disorders: A systematic review
2016-01-01 Gressier, F; Calati, R.; Serretti, A.
5-HTTLPR rs25531A > G differentially influence paroxetine and fluvoxamine antidepressant efficacy: a randomized, controlled trial.
2013-01-01 Kato M; Nonen S; Serretti A; Tetsuo S; Takekita Y; Azuma J; Kinoshita T.
A genetic dissection of antipsychotic induced movement disorders.
2013-01-01 Crisafulli C; Drago A; Sidoti A; Serretti A.
A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression.
2004-01-01 Benedetti F.; Serretti A.; Colombo C.; Lorenzi C.; Tubazio V.; Smeraldi E.
A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics.
2011-01-01 Serretti A.; Chiesa A.
A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders.
2011-01-01 A. Serretti; P. Olgiati; E. Bajo; M. Bigelli; D. De Ronchi
A neural network model for combining clinical predictors of antidepressant response in mood disorders
2007-01-01 Serretti A.; Zanardi R.; Mandelli L.; Smeraldi E.; Colombo C.
A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression.
2011-01-01 Serretti A.; Chiesa A.; Calati R.; Massat I.; Linotte S.; Kasper S.; Lecrubier Y.; Antonijevic I.; Forray C.; Snyder L.; Bollen J.; Zohar J.; De Ronchi D.; Souery D.; Mendlewicz J.
A preliminary investigation on the influence of the interactions of comorbid axis I disorders on clinical improvement to duloxetine treatment in patients with major depression
2010-01-01 Mencacci C.; Chiesa A.; Di Nasso E.; De Ronchi D.; Serretti A.
A protective genetic variant for adverse environments? The role of childhood traumas and serotonin transporter gene on resilience and depressive severity in a high-risk population
2011-01-01 Carli V; Mandelli L; Zaninotto L; Roy A; Recchia L; Stoppia L; Gatta V; Sarchiapone M; Serretti A.
A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder.
2004-01-01 Benedetti; F.; Bernasconi; A.; Lorenzi; C.; Pontiggia; A.; Serretti; A.; Colombo; C.; Smeraldi; E.
A systematic review of neurobiological and clinical features of mindfulness meditations
2010-01-01 Chiesa A.; Serretti A.
A targeted use of DNA microarrays in the pharmacogenetics of antidepressants: pros and cons
2004-01-01 Lorenzi C.; Tubazio V.; Ploia C.; Serretti A.; De Ronchi D.;